The global 𝐎𝐯𝐞𝐫-𝐭𝐡𝐞-𝐜𝐨𝐮𝐧𝐭𝐞𝐫 (𝐎𝐓𝐂) 𝐝𝐫𝐮𝐠𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 is anticipated to witness substantial growth in the coming years, as revenue is expected to increase from 𝐔𝐒$ 𝟏,𝟐𝟗,𝟗𝟔𝟑.𝟎𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟐 𝐭𝐨 𝐔𝐒$ 𝟐,𝟑𝟖,𝟒𝟓𝟑.𝟗𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, marking a compound annual growth rate (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟕.𝟎% over the forecast period. This growth trajectory underscores the increasing demand for accessible...